Drug use-results survey on safety and efficacy of Rupafin tablets 10 mg
Not Applicable
- Conditions
- Allergic rhinitis Hives and itch associated with skin diseases ( eczema / dermatitis, cutaneous pruritus)
- Registration Number
- JPRN-UMIN000031332
- Lead Sponsor
- TEIKOKU SEIYAKU CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2500
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of hypersensitivity to the active substance or to any of the excipients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method